Repligen CorporationRGENNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
1.55%
↓ 80% below average
Average (39q)
7.63%
Historical baseline
Range
High:75.79%
Low:-37.70%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 1.55% |
| Q2 2025 | 8.00% |
| Q1 2025 | 10.68% |
| Q4 2024 | 20.26% |
| Q3 2024 | -5.65% |
| Q2 2024 | -8.43% |
| Q1 2024 | 9.27% |
| Q4 2023 | -2.76% |
| Q3 2023 | 8.97% |
| Q2 2023 | -20.14% |
| Q1 2023 | 9.37% |
| Q4 2022 | 8.65% |
| Q3 2022 | -2.03% |
| Q2 2022 | -14.11% |
| Q1 2022 | 33.29% |
| Q4 2021 | -0.38% |
| Q3 2021 | 9.12% |
| Q2 2021 | 10.21% |
| Q1 2021 | 14.14% |
| Q4 2020 | 50.81% |
| Q3 2020 | 1.98% |
| Q2 2020 | -7.78% |
| Q1 2020 | -9.09% |
| Q4 2019 | -4.70% |
| Q3 2019 | 3.75% |
| Q2 2019 | 44.50% |
| Q1 2019 | 16.81% |
| Q4 2018 | -13.94% |
| Q3 2018 | -37.70% |
| Q2 2018 | 75.79% |
| Q1 2018 | 7.17% |
| Q4 2017 | 53.32% |
| Q3 2017 | 7.58% |
| Q2 2017 | 6.77% |
| Q1 2017 | -14.61% |
| Q4 2016 | 8.17% |
| Q3 2016 | -0.21% |
| Q2 2016 | 22.81% |
| Q1 2016 | 7.55% |
| Q4 2015 | -3.96% |